Cimple is a pioneering biotech firm spun off from HK Tech 300 at City University of Hong Kong and Incu-Bio in Hong Kong Science Park. The core of Cimple's innovation is the result of over a decade of R&D by Professor Chen Ting-Hsuan's team at CityU, which culminated in the creation of a quantitative rapid test that addresses a significant market gap, as only qualitative rapid test devices were previously available. This groundbreaking technology enables customers to accurately monitor their health status from the comfort of their own homes.
Dr Liu Wengang (Alumnus, Department of Biomedical Engineering, CityU)
Prof Chen Ting-Hsuan (Associate Professor, Department of Biomedical Engineering, CityU)
Dr Cui Chenyu (Alumna, Department of Biomedical Engineering, CityU)
(Info based on the company's application form)
- CityU HK Tech 300 Angel Fund (2024)
- CityU HK Tech 300 Seed Fund (2022)
- HKSTP Incu-Bio (2024)